Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice.
Ryo AokiMasayoshi OnukiKoya HattoriMasato ItoTakahiro YamadaKohei KamikadoYun-Gi KimNobuhiro NakamotoIkuo KimuraJulie M ClarkeTakanori KanaiKoji HasePublished in: Microbiome (2021)
These findings demonstrated that the commensal microbiome-acetate-FFAR2 molecular circuit improves insulin sensitivity in the liver and prevents the development of NAFLD/NASH. Video abstract.